Fig. 4

Hypothesized influence of treatment history on co-occurrence of mutated PIK3CA and HER2 overexpression. HER human epidermal growth factor receptor, PIK3CA phosphoinositide 3-kinase catalytic subunit alpha, T-DM1 trastuzumab emtansine